Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 18c; Bumps Guidance Slightly

Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $1.82, $0.18 better than the analyst estimate of $1.64. Revenue for the quarter came in at $1.78 billion versus the consensus estimate of $1.72 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2022 EPS of $6.70-$6.90, versus prior of $6.65-$6.85 and the consensus of $6.72. Sees revenue -1% to +1%.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
• Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance